Evidence map›Paper›PMID 41586349›Full record

ArticleBiomaterials and biosystems2026

Comparative analysis of different macromolecular crowding agents in human tenocyte cultures.

Andrea Rossoni, Giovanni Lauretta, Stephen Kearns, Dimitrios I Zeugolis

Abstract read
In one paragraph

Article in Biomaterials and biosystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrea RossoniRegenerative, Modular & Developmental Engineering Laboratory (REMODEL), Charles Institute of Dermatology, Conway Institute of Biomolecular & Biomedical Research and School of Mechanical & Materials Engineering, University College Dublin (UCD), Dublin, Ireland.
Giovanni LaurettaRegenerative, Modular & Developmental Engineering Laboratory (REMODEL), Charles Institute of Dermatology, Conway Institute of Biomolecular & Biomedical Research and School of Mechanical & Materials Engineering, University College Dublin (UCD), Dublin, Ireland.
Stephen KearnsBon Secours Hospital, Merlin Park Regional Hospital, University Hospital Galway and University of Galway, Galway, Ireland.
Dimitrios I ZeugolisRegenerative, Modular & Developmental Engineering Laboratory (REMODEL), Charles Institute of Dermatology, Conway Institute of Biomolecular & Biomedical Research and School of Mechanical & Materials Engineering, University College Dublin (UCD), Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tendon engineered substitutes remain clinically unavailable, largely due to the need for prolonged culture periods to allow for sufficient extracellular matrix deposition. Although macromolecular crowding allows for accelerated extracellular matrix deposition, the optimal macromolecular crowding agent in human tenocyte cultures is still unknown. Here, we measured the physicochemical properties of six macromolecules (κλ carrageenan, λ carrageenan, polysucrose, polyacrylic acid, hyaluronic acid and polyvinylpyrrolidone) and assessed their effect in human tenocyte basic function, collagen type I deposition and gene expression. The κλ carrageenan exhibited the highest polydispersity index. None of the macromolecules impaired cell viability and metabolic activity. The κλ carrageenan and the λ carrageenan significantly enhanced collagen type I deposition. A macromolecular crowding agent dependent gene expression was observed, with the κλ carrageenan appearing to induce a more mature phenotype. This study provides a framework for selecting an appropriate macromolecular crowding agent to enhance and accelerate extracellular matrix deposition, whilst maintaining acceptable cell function.

Indexed as

Extracellular matrixMacromolecular crowdingTendon cellsTendon engineering

Identifiers

PMID41586349
PMCPMC12828578

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.